In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded 32P-nHA Nanoparticles in Prostate Cancer Therapy
International Journal of Nanomedicine · 2023
DOI: 10.2147/ijn.s403887 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift International Journal of Nanomedicine, 2023. Verfasst von Hao Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China. Hauptthemen laut MEDLINE: Nanoparticles, Prostatic Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.
- Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, 400030, People's Republic of China.
ORCID-Profile: Hao Deng, Xiaoliang Chen
Zitieren
APA
Deng, H., Wang, Y., Zhou, Y., Zhai, D., Chen, J., Hao, S., & Chen, X. (2023). In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded 32P-nHA Nanoparticles in Prostate Cancer Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s403887
Vancouver
Deng H, Wang Y, Zhou Y, Zhai D, Chen J, Hao S, et al. In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded 32P-nHA Nanoparticles in Prostate Cancer Therapy. International Journal of Nanomedicine. 2023. doi:10.2147/ijn.s403887
BibTeX
@article{Deng2023,
author = {Deng, Hao and Wang, Yumei and Zhou, Yue and Zhai, Dongliang and Chen, Jie and Hao, Shilei and Chen, Xiaoliang},
title = {In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded 32P-nHA Nanoparticles in Prostate Cancer Therapy},
journal = {International Journal of Nanomedicine},
year = {2023},
doi = {10.2147/ijn.s403887}
}
EUVIMED